Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Zalicus Inc (NASDAQ:ZLCS) will merge with Epirus Biopharmaceuticals in an all-stock transaction. Zalicus will be known as Epirus and will operate under the latter company’s management team led by Amit Munshi as president and CEO. Current Zalicus Inc (NASDAQ:ZLCS) stockholders will own approximately 19% of the company. The merger will create a publicly-traded company listed on the NASDAQ. Zalicus Inc (NASDAQ:ZLCS) stock performance was 31.07% … Continue reading Biotech Unusual Volume: Zalicus Inc (NASDAQ:ZLCS), ImmunoGen (NASDAQ:IMGN), Transition Therapeutics (NASDAQ:TTHI), Lpath (NASDAQ:LPTN)

Colin Pettis04/1704/17

Momentum Stocks : J. C. Penney Company, Inc. (NYSE:JCP), GT Advanced Technologies Inc. (NASDAQ:GTAT), Nokia Corporation (ADR) (NYSE:NOK), Progressive Corp. (NYSE:PGR), TTHI

J.C. Penney Co. Inc. (NYSE:JCP) has watched its stock drop since it released its $3.5 billion growth plans and lowered its third-quarter guidance. The day of the meeting, Oct. 8, the Plano-based retailer’s stock opened trading at $9.25 per share. After Penney (NYSE: JCP) announced plans that included updates to the core centers of its stores, its home department and a renewed focus on its … Continue reading Momentum Stocks : J. C. Penney Company, Inc. (NYSE:JCP), GT Advanced Technologies Inc. (NASDAQ:GTAT), Nokia Corporation (ADR) (NYSE:NOK), Progressive Corp. (NYSE:PGR), TTHI

Mark Doerr10/13